Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowHeather Turner, CEO of LB Pharmaceuticals (NSDQ: LBRX), sits down with Nasdaq’s Kristina Ayanian to discuss LB Pharma’s mission to transform neuropsychiatric care and the company’s recent IPO milestone. She also shares insights on innovation, leadership in biotech, and what’s next for LB Pharma.